Zilong Shen

772 total citations
36 papers, 632 citations indexed

About

Zilong Shen is a scholar working on Molecular Biology, Microbiology and Immunology. According to data from OpenAlex, Zilong Shen has authored 36 papers receiving a total of 632 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 12 papers in Microbiology and 6 papers in Immunology. Recurrent topics in Zilong Shen's work include Antimicrobial Peptides and Activities (12 papers), Aquaculture disease management and microbiota (4 papers) and Biochemical and Structural Characterization (4 papers). Zilong Shen is often cited by papers focused on Antimicrobial Peptides and Activities (12 papers), Aquaculture disease management and microbiota (4 papers) and Biochemical and Structural Characterization (4 papers). Zilong Shen collaborates with scholars based in China, United States and Italy. Zilong Shen's co-authors include Guoqiu Wu, Tao Xi, Xiaobo Fan, Linxian Li, Rui Zhao, Huiping Zhou, Hongbin Wu, Can Zhang, Qinglong Guo and Ding Qi-long and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomaterials and Biochemical and Biophysical Research Communications.

In The Last Decade

Zilong Shen

32 papers receiving 617 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zilong Shen China 13 299 230 133 85 61 36 632
Yuan Lyu China 16 325 1.1× 102 0.4× 38 0.3× 52 0.6× 25 0.4× 40 547
Maciej Jaśkiewicz Poland 17 411 1.4× 333 1.4× 48 0.4× 65 0.8× 23 0.4× 38 851
Anja Pfalzgraff Germany 8 352 1.2× 328 1.4× 45 0.3× 157 1.8× 12 0.2× 8 678
Sandra Pinto Portugal 12 275 0.9× 216 0.9× 92 0.7× 51 0.6× 22 0.4× 18 606
Paula Parreira Portugal 14 179 0.6× 116 0.5× 73 0.5× 59 0.7× 36 0.6× 30 524
Leonardo Delello Di Filippo Brazil 18 323 1.1× 50 0.2× 245 1.8× 49 0.6× 158 2.6× 54 871
Jamie L. Burgess United States 11 171 0.6× 39 0.2× 152 1.1× 36 0.4× 33 0.5× 16 937
Carlos Alberto-Silva Brazil 18 272 0.9× 104 0.5× 37 0.3× 13 0.2× 63 1.0× 56 742
Ana Paula Perez Argentina 12 262 0.9× 43 0.2× 65 0.5× 86 1.0× 201 3.3× 20 592

Countries citing papers authored by Zilong Shen

Since Specialization
Citations

This map shows the geographic impact of Zilong Shen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zilong Shen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zilong Shen more than expected).

Fields of papers citing papers by Zilong Shen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zilong Shen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zilong Shen. The network helps show where Zilong Shen may publish in the future.

Co-authorship network of co-authors of Zilong Shen

This figure shows the co-authorship network connecting the top 25 collaborators of Zilong Shen. A scholar is included among the top collaborators of Zilong Shen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zilong Shen. Zilong Shen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shen, Zilong, Mingjie Wu, Yun Ling, et al.. (2025). Lingguizhugan decoction improves cognitive impairment in APP/PS1 mice by promoting meningeal lymphatic drainage based on fatty acid degradation pathway. Journal of Ethnopharmacology. 355(Pt B). 120748–120748.
2.
Shen, Zilong, Jiahao Song, Xiyuan Tang, et al.. (2024). SAGERoute 2.0: Hierarchical Analog and Mixed Signal Routing Considering Versatile Routing Scenarios. 1–6. 3 indexed citations
3.
Si, Zhenxing, et al.. (2023). Increased circulating microRNA-21 level as a potential indicator for predicting a higher risk of incident fragility fractures. Journal of Osteopathic Medicine. 124(3). 121–125. 1 indexed citations
4.
Shen, Zilong, Zhengmei Zhang, & Wenjing Zhao. (2022). Relationship between plasma homocysteine and chronic kidney disease in US patients with type 2 diabetes mellitus: a cross-sectional study. BMC Nephrology. 23(1). 419–419. 8 indexed citations
6.
Gao, Yanbin, et al.. (2019). Effect of Baoshenfang Formula on Podocyte Injury via Inhibiting the NOX-4/ROS/p38 Pathway in Diabetic Nephropathy. Journal of Diabetes Research. 2019. 1–16. 24 indexed citations
7.
Ren, Xiaoping, et al.. (2015). Head Transplantation in Mouse Model. CNS Neuroscience & Therapeutics. 21(8). 615–618. 16 indexed citations
8.
Ren, Xiaoping, et al.. (2014). Allogeneic Head and Body Reconstruction: Mouse Model. CNS Neuroscience & Therapeutics. 20(12). 1056–1060. 10 indexed citations
10.
Wu, Guoqiu, et al.. (2012). Subacute toxicity of antimicrobial peptide S-thanatin in ICR mice. Peptides. 36(1). 109–113. 11 indexed citations
11.
Cirioni, Oscar, Guoqiu Wu, Linxian Li, et al.. (2011). S-thanatin in vitro prevents colistin resistance and improves its efficacy in an animal model of Pseudomonas aeruginosa sepsis. Peptides. 32(4). 697–701. 9 indexed citations
12.
Wu, Guoqiu, Xiaofang Li, Xiaobo Fan, et al.. (2011). The activity of antimicrobial peptide S-thanatin is independent on multidrug-resistant spectrum of bacteria. Peptides. 32(6). 1139–1145. 29 indexed citations
13.
Wu, Guoqiu, Xiaofang Li, Xuepeng Deng, et al.. (2010). Protective effects of antimicrobial peptide S-thanatin against endotoxic shock in mice introduced by LPS. Peptides. 32(2). 353–357. 8 indexed citations
14.
Wu, Guoqiu, Xiaobo Fan, Linxian Li, et al.. (2010). Interaction of antimicrobial peptide s-thanatin with lipopolysaccharide in vitro and in an experimental mouse model of septic shock caused by a multidrug-resistant clinical isolate of Escherichia coli. International Journal of Antimicrobial Agents. 35(3). 250–254. 37 indexed citations
15.
Cirioni, Oscar, Guoqiu Wu, Linxian Li, et al.. (2010). S-thanatin enhances the efficacy of tigecycline in an experimental rat model of polymicrobial peritonitis. Peptides. 31(7). 1231–1236. 7 indexed citations
16.
Wu, Guoqiu, Hongbin Wu, Xiaobo Fan, et al.. (2010). Selective toxicity of antimicrobial peptide S-thanatin on bacteria. Peptides. 31(9). 1669–1673. 30 indexed citations
17.
Wu, Guoqiu, Hongbin Wu, Linxian Li, et al.. (2010). Membrane aggregation and perturbation induced by antimicrobial peptide of S-thanatin. Biochemical and Biophysical Research Communications. 395(1). 31–35. 30 indexed citations
18.
Zhang, Can, Guowei Qu, Xiaoli Wu, et al.. (2008). Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel. Biomaterials. 29(9). 1233–1241. 167 indexed citations
19.
Shen, Zilong. (2005). Pharmacokinetics of fructose 1,6 diphosphate magnesium in Beagle dogs. Zhongguo sheng-hua yaowu zazhi. 1 indexed citations
20.
Shen, Zilong. (2002). Transgenic Plants Technology and Its Application for Bioproductions. Pharmaceutical biotechnology. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026